Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment.
Previous studies have shown that the G-actin sequestering polypeptide thymosin beta4 frequently is overexpressed in cancers and that such overexpression correlates to malignant progression. However, the localization of thymosin beta4 in human cancers has not been determined. We now demonstrate that there is a considerable heterogeneity in the cellular distribution of thymosin beta4 in breast cancer. In most tumors examined, cancer cells showed low or intermediate reactivity for thymosin beta4, whereas leukocytes and macrophages showed intense reactivity. In addition, endothelial cells showed variable reactivity to thymosin beta4, whereas myofibroblasts were negative. There was no correlation between the intensity of tumor cell staining and histological grade, whereas there was a tendency toward a correlation between endothelial cell staining and grade. These results demonstrate that multiple cell types within the tumor microenvironment produce thymosin beta4 and that such expression varies from tumor to tumor. Such heterogeneity of expression should be taken into account when the role of thymosin beta4 in tumor biology is assessed.
Larsson
Lars-Inge
LI
Anatomy and Cell Biology, Institute for Basic Animal and Veterinary Science, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Copenhagen, Denmark. lail@kvl.dk
Holck
Susanne
S
D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D042783:Endothelial Cells / Q000737:chemistry; D005260:Female; D005455:Fluorescent Antibody Technique / Q000379:methods; D006801:Humans; D007962:Leukocytes / Q000737:chemistry / Q000473:pathology; D008264:Macrophages / Q000737:chemistry / Q000473:pathology; D017154:Stromal Cells / Q000737:chemistry / Q000473:pathology; D013947:Thymosin / Q000032:analysis*; D000099201:Thymosin beta(4)
D013947:Thymosin; D000099201:Thymosin beta(4)